1 – 10 of 543
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2016
- An embryonic stem cell activated FOXM1 transcriptional program marks ultra-high-risk primary neuroblastoma patients for FDI-6 small molecule inhibition
- LIN28B is over-expressed in specific subtypes of pediatric leukemia and regulates lncRNA H19
- The genomic region encompassing the overlapping SOX11 and Lnc-SOX11-1:1 loci exhibits a complex DNA copy number and mRNA expression pattern
- LIN28B overexpression defines a novel fetal-like subgroup of juvenile myelomonocytic leukemia
- GATA3 induces human T-cell commitment by restraining Notch activity and repressing NK-cell fate
- Long noncoding RNA signatures define oncogenic subtypes in T-cell acute lymphoblastic leukemia
- Identification of non-invasive biomarkers for treatment response in neuroblastoma by circulating miRNA profiling
- Detection of copy number aberrations in cell free DNA from plasma of neuroblastoma patients using shallow massive parallel sequencing
- Targeting MYCN-driven transcription by BET-bromodomain inhibition
- MYCN and HDAC5 transcriptionally repress CD9 to trigger invasion and metastasis in neuroblastoma